Joint Stock Company National Atomic Company Kazatomprom — Kazatomprom announces 1H2026 Financial Results

Revenue up, but profits and cash flow down as costs rise and project delays emerge.

What the company is saying

Kazatomprom reports a 9% year-on-year increase in consolidated revenue to KZT 717,834 million for the first half of 2026, highlighting this as a sign of financial discipline and favorable uranium market conditions. The company emphasizes the completion of its 2025 dividend payout, totaling KZT 335.16 billion or KZT 1,292.27 per share, following shareholder approval in May 2026. Operationally, Kazatomprom spotlights the commissioning of a new processing plant at the Zhalpak deposit with a 500-tonne annual capacity, and signals plans to expand this to 900 tonnes in 2027. The announcement acknowledges a regulatory-driven delay for the TQZ sulphuric acid plant, shifting its commissioning by 6–12 months into late 2027 or early 2028. The tone is neutral and factual, with most claims grounded in disclosed numbers, though the link between revenue growth and management discipline or market strength is asserted without direct evidence. CEO Meirzhan Yussupov is named, but no new institutional involvement is highlighted.

What the data suggests

The headline revenue increase to KZT 717,834 million is offset by a 9% decline in net profit to KZT 240,428 million and a sharp 55% drop in operating cash flow to KZT 239,590 million. Attributable EBITDA fell 12% to KZT 264,840 million, while adjusted EBITDA edged up 2% to KZT 371,252 million, indicating margin pressure. Cost of sales rose 14% to KZT 427,519 million, and selling expenses jumped 23% to KZT 14,819 million, both outpacing revenue growth and compressing profitability. Total cash increased modestly by 4% since year-end 2025, but is down 38% from the prior June. The dividend payout of KZT 335.16 billion is confirmed as completed. The commissioning of the Zhalpak plant (500 tonnes) is a realised operational milestone, but the planned expansion and delayed TQZ project are forward-looking and not yet contributing to results. The data points to deteriorating profitability and cash generation despite higher sales, with rising costs and project delays as key headwinds.

Analysis

The announcement is factual and proportionate, with the majority of claims supported by realised, numerical evidence. Key financial metrics—including revenue, net profit, EBITDA, and cash flow—are disclosed, and operational milestones such as the commissioning of a new processing plant are reported as completed events. Forward-looking statements (e.g., planned expansion to 900 tonnes in 2027, delayed TQZ commissioning) are clearly separated from realised results and do not dominate the narrative. While revenue increased, profitability and cash flow metrics declined, which is transparently disclosed. There is no evidence of exaggerated language or narrative inflation; the tone remains neutral and avoids promotional phrasing. The only minor unsupported claim is the attribution of revenue growth to 'financial discipline and favorable uranium market conditions,' which lacks direct numerical backing.

Risk flags

• ●Profitability is under pressure as cost of sales (up 14%) and selling expenses (up 23%) outpace the 9% revenue increase, compressing margins and reducing net profit by 9%. This trend, if sustained, could erode returns even if top-line growth continues.
• ●Operating cash flow dropped 55% year-on-year to KZT 239,590 million, raising concerns about the company's ability to internally fund dividends, capex, or debt repayments without drawing down cash reserves or increasing leverage.
• ●The TQZ sulphuric acid plant faces a 6–12 month regulatory delay, with commissioning now expected between Q3 2027 and Q1 2028. This introduces uncertainty around future production capacity and may impact 2027 guidance, depending on the availability of alternative sulphuric acid sources.
• ●Forward-looking claims about 'financial discipline' and 'favorable uranium market conditions' are not substantiated with specific data, making it harder to assess whether management actions or external factors are driving results.

Bottom line

Kazatomprom's half-year results show rising revenue but falling profits and sharply weaker cash generation, as cost inflation outpaces sales growth. The dividend payout is confirmed and the new Zhalpak plant is operational, but the benefit of planned expansions and the delayed TQZ facility will not be felt until at least late 2027. The company's narrative is mostly grounded in realised numbers, but the claim that results reflect management discipline or market strength lacks direct evidence. Margin compression and project execution delays are the main risks, with no immediate catalysts for a turnaround visible in the data. Investors should focus on whether cost pressures can be contained and whether future project milestones are met on the revised schedule. The most important takeaway: headline growth masks underlying financial deterioration and rising execution risk.

Announcement summary

(LSE: KAP) National Atomic Company "Kazatomprom" JSC announced its consolidated financial results for six months ended 30 June 2026, prepared in accordance with International Financial Reporting Standards (IFRS). Consolidated revenue showed a 9% year-on-year growth to almost 718 billion tenge. The Company has completed the payment of its 2025 dividends to shareholders on 29 July 2026, with a total of KZT 335,158,763,820.16 or KZT 1,292.27 per one ordinary share paid out. On 29 July 2026, the Zhalpak processing plant, with an annual capacity of up to 500 tonnes, was commissioned, and expansion to the nominal capacity of 900 tonnes is planned for 2027. Due to the regulatory suspension of work at the affected zone, the scheduled commissioning date for TQZ, originally targeted for the first quarter of 2027, is now projected to occur between the third quarter of 2027 and the first quarter of 2028, representing an anticipated project schedule shift of 6 to 12 months. As at 30 June 2026, total cash and cash equivalents, including current term deposits, amounted to KZT 360,697 million, increasing by 4% compared to KZT 347,426 million as at 31 December 2025. Cost of sales totalled KZT 427,519 million in the first half of 2026, a 14% year-on-year increase. Selling expenses totalled KZT 14,819 million in the first half of 2026, a 23% year-on-year increase.

Disagree with this article?